National Library of Medicine, Office of Acquisitions Management, Building 38A, Room B1N17, 8600 Rockville Pike, Bethesda, Maryland 20894

R -- PROCUREMENT OF THE UNITED STATES PHARMOCOPOECIA DRUG INDEX (USP DI) VOLUME II FOR ACCESS THROUGH NLM INTERNET SITE SOL NLM 00-010/UHP DUE 110399 POC Uyen H. Phuong (301) 496-6127 E-MAIL: karen_riggs@nlm.nih.gov, uyen_phuong@nlm.nih.gov. It is the intent of the National Library of Medicine (NLM) to procure the United States Pharmacopoeia Drug Index (USP DI) Volume II -- Information for the Patient for access through Medlineplus, an NLM internet site, on a sole source basis with Micromedex, Inc., 6200 South Syracuse Way, Suite 300, Englewood, Colorado, 80111. Micromedex, Inc. has been given proprietary right to market the USP DI by the United States Pharmacopoeia. The NLM is developing and managing Medlineplus, an easily understandable WorldWide Web resource to assist consumers in obtaining the information they need to make informed decisions about health care. Medlineplus links to MEDLINE, the world's largest database of peer-reviewed information, as well as to self-help groups, the National Institutes of Health (NIH) consumer health information site, clearinghouses, health-related organizations, and clinical trials. In addition to general health topics, Medlineplus provides access to extensive, authoritative information about specific diseases and conditions ("Health Topics"). The site will be continuously expanded, and it is expected to include comprehensive and cutting-edge information on hundreds of diseases and conditions in coming months. The purpose of this procurement is to obtain access to the authoritative, consumer-oriented drug information needed to complement other information available on the site. The USP is the organization that sets the official standards of strength, quality, purity, packaging and labeling for medical products used in the United States. Congress has recognized the USP and the national Formulary as the official U.S. compendia for standards for drugs and for the inactive ingredients in drug dosage forms. The USP DI is the unquestioned American source for independent, authoritative information on drugs marketed in the United States and Canada. Volume I of the USP DI, contains drug use information in technical language for the professional health care provider (e.g. physicians, pharmacists, nurses, etc.). Volume II, the product which the NLM intends to procure, is its lay language counterpart for use by consumers. The proposed acquisition will be procured under FAR Part 12 -- Acquisition of Commercial Items. This notice of intent is not a Request for Quotations (RFQ) nor is an RFQ available; however, all responsible and responsive sources may submit a proposal which will be considered by the NLM. Firms interested in responding to this notice must be able to sufficiently demonstrate the firm's ability to meet the government's requirements as stated above. Responses are required within fifteen (15) calendar days from the publication date of this notice. NLM synopsis No. NLM 00-010/UHP. Inquires regarding this procurement may be made to Uyen H. Phuong, Lead Purchasing Agent, NLM on (301) 496-6127. Posted 10/15/99 (W-SN392146). (0288)

Loren Data Corp. http://www.ld.com (SYN# 0068 19991019\R-0012.SOL)